Trial Profile
Phase IV: Effect of Testosterone on Endothelial Function and Microcirculation in Type 2 Diabetic Patients With Hypogonadism
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Testosterone (Primary) ; Vardenafil
- Indications Hypogonadism
- Focus Pharmacodynamics
- 07 Feb 2019 Status changed from recruiting to discontinued.
- 20 Jan 2014 Planned End Date changed from 1 Sep 2012 to 1 May 2015 as reported by ClinicalTrials.gov record.
- 28 Apr 2012 Actual Initiation Date 19 Apr 2012 added as reported by European Clinical Trials Database.